Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma

References

• Cheung NK, Dyer MA. Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat Rev Cancer 2013; 13:397-11; PMID:23702928; https://doi.org/10.1038/nrc3526
   PubMed Web of Science ®Google Scholar
• Mossé YP, Deyell RJ, Berthold F, Nagakawara A, Ambros PF, Monclair T, Cohn SL, Pearson AD, London WB, Matthay KK. Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project. Pediatr Blood Cancer 2014; 61:627-35; PMID:24038992; https://doi.org/10.1002/pbc.24777
   PubMed Web of Science ®Google Scholar
• Ejeskar K, Aburatani H, Abrahamsson J, P Kogner P, Martinsson T. Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene. Br J Cancer 1998; 77:1787-91; PMID:9667647; https://doi.org/10.1038/bjc.1998.297
   PubMed Web of Science ®Google Scholar
• van Mater D, Knelson EH, Kaiser-Rogers KA, Armstrong MB. Neuroblastoma in a pediatric patient with a microduplication of 2p involving the MYCN locus. Am J Med Genet 2013; 161:605-10; PMID:23401364; https://doi.org/10.1002/ajmg.a.35766
   PubMed Web of Science ®Google Scholar
• Tassano E, Biancheri R, Denegri L, Porta S, Novara F, Zuffardi O, Gimelli G, Cuoco C. Heterozygous deletion of CHL1 gene: detailed array-CGH and clinical characterization of a new case and review of the literature. Eur J Med Genet 2014; 57:626-9; PMID:25451713; https://doi.org/10.1016/j.ejmg.2014.09.007
   PubMed Web of Science ®Google Scholar
• Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, Carter SL, Cibulskis K, Hanna M, Kiezun  , et al. The genetic landscape of high-risk neuroblastoma. Nat Genet 2013; 45:279-84; PMID:23334666; https://doi.org/10.1038/ng.2529
   PubMed Web of Science ®Google Scholar
• Laureys G, Speleman F, Opdenakker G, Benoit Y, Leroy J. Constitutional translocation t(1;17)(p36;q12-21) in a patient with neuroblastoma. Genes Chromosomes Cancer 1990; 2:252-4; PMID:2078517; https://doi.org/10.1002/gcc.2870020315
   PubMed Web of Science ®Google Scholar
• Biegel JA, White PS, Marshall HN, Fujimori M, Zackai EH, Scher CD, Brodeur GM, Emanuel BS. Constitutional 1p36 deletion in a child with neuroblastoma. Am J Hum Genet 1993; 52:176-82; PMID:8434586
   PubMed Web of Science ®Google Scholar
• Koiffmann CP, Gonzalez CH, Vianna-Morgante AM, Kim CA, Odone-Filho V, Wajntal A. Neuroblastoma in a boy with MCA/MR syndrome, deletion 11q, and duplication 12q. Am J Med Genet 1995; 58:46-9; PMID:7573155; https://doi.org/10.1002/ajmg.1320580110
   PubMed Web of Science ®Google Scholar
• Roberts T, Chernova O, Cowell JK. NB4S, a member of the TBC1 domain family of genes, is truncated as a result of a constitutional t(1;10)(p22;q21) chromosome translocation in a patient with stage 4S neuroblastoma. Hum Mol Genet 1998; 7:1169-78; PMID:9618176; https://doi.org/10.1093/hmg/7.7.1169
   PubMed Web of Science ®Google Scholar
• Anderson J, Kempski H, Hill L, Rampling D, Gordon T, Michalski A. Neuroblastoma in monozygotic twins: a case of probable twin-to-twin metastasis. Br J Cancer 2001; 85:493-6; PMID:11506485; https://doi.org/10.1054/bjoc.2001.1979
   PubMed Web of Science ®Google Scholar
• Yuksel A, Seven M, Karaman B, Yilmaz S, Deviren A, Hacihanefioglu S, Basaran S. Neuroblastoma in a dysmorphic girl with a partial duplication of 2p caused by an unbalanced translocation. Clin Dysmorphol 2002; 11:39-42; PMID:11822704; https://doi.org/10.1097/00019605-200201000-00008
   PubMed Web of Science ®Google Scholar
• Satgé D, Moore SW, Stiller CA, Niggli FK, Pritchard-Jones K, Bown N, Bénard J, Plantaz D. Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literature. Cancer Genet Cytogenet 2003; 147:89-98; PMID:14623457; https://doi.org/10.1016/S0165-4608(03)00203-6
   PubMedGoogle Scholar
• Mossé Y, Greshock J, King A, Khazi D, Weber BL, Maris JM. Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastoma. Lancet Oncol 2003; 4:769-71; PMID:14662434; https://doi.org/10.1016/S1470-2045(03)01283-X
   PubMed Web of Science ®Google Scholar
• Dowa Y, Yamamoto T, Abe Y, Kobayashi M, Hoshino R, Tanaka K, Aida N, Take H, Kato K, Tanaka Y, et al. Congenital neuroblastoma in a patient with partial trisomy of 2p. J Pediatr Hematol Oncol 2006; 28:379-82; PMID:16794507; https://doi.org/10.1097/00043426-200606000-00011
   PubMed Web of Science ®Google Scholar
• Vandepoele K, Andries V, Van Roy N, Staes K, Vandesompele J, Laureys G, De Smet E, Berx G, Speleman F, van Roy F. A Constitutional Translocation t(1;17)(p36.2;q11.2) in a Neuroblastoma Patient Disrupts the Human NBPF1 and ACCN1 Genes. PlosOne 2008; 3:5 e2207; PMID:18493581; https://doi.org/10.1371/journal.pone.0002207
   PubMed Web of Science ®Google Scholar
• Bertrand I, Le Cunff M, Boceno M, Boisseau P, Thomas C, Rival JM, David A, Le Caignec C. Complex constitutional subtelomeric 1p36.3 deletion/duplication in a mentally retarded child with neonatal neuroblastoma. Eur J Med Genet 2008; 51:679e684; PMID:18672103; https://doi.org/10.1016/j.ejmg.2008.06.004
   PubMed Web of Science ®Google Scholar
• Lipska BS, Koczkowska M, Wierzba J, Ploszynska A, Iliszko M, Izycka-Swieszewska E, Adamkiewicz-Drozynska E, Limon J. On the significance of germline cytogenetic rearrangements at MYCN locus in neuroblastoma. Mol Cytogenetics 2013; 6:43; PMID:24131700; https://doi.org/10.1186/1755-8166-6-43
   PubMed Web of Science ®Google Scholar
• Passariello A, De Brasi D, Defferrari R, Genesio R, Tufano M, Mazzocco K, Capasso M, Migliorati R, Martinsson T, Siani P, et al. Constitutional 11q14-q22 chromosome deletion syndrome in a child with neuroblastoma MYCN single copy. Eur J Med Genet 2013; 56:626-34; PMID:24035971; https://doi.org/10.1016/j.ejmg.2013.08.005
   PubMed Web of Science ®Google Scholar
• van Mater D, Knelson EH, Kaiser-Rogers KA, Armstrong MB. Neuroblastoma in a pediatric patient with a microduplication of 2p in1volving the MYCN locus. Am J Med Genet 2013; 161:605-10; PMID:23401364; https://doi.org/10.1002/ajmg.a.35766
   PubMed Web of Science ®Google Scholar
• Janoueix-Lerosey I, Lequin D, Brugieres L, Ribeiro A, de Pontual L, Combaret V, Raynal V, Puisieux A, Schleiermacher G, Pierron G, et al. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature 2008; 455:967-70; PMID:18923523; https://doi.org/10.1038/nature07398
   PubMed Web of Science ®Google Scholar
• Girirajan S, Rosenfeld JA, Coe BP, Parikh S, Friedman N, Goldstein A, Filipink RA, McConnell JS, Angle B, Meschino WS, et al. Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med 2012; 367:1321-31; PMID:22970919; https://doi.org/10.1056/NEJMoa1200395
   PubMed Web of Science ®Google Scholar
• Hansford LM, Smith SA, Haber M, Norris MD, Cheung B, Marshall GM. Cloning and characterization of the human neural cell adhesion molecule, CNTN4 (alias BIG-2). Cytogenet Genome Res 2003; 101:17-23; PMID:14571131; https://doi.org/10.1159/000073412
   PubMed Web of Science ®Google Scholar
• Yoshihara Y, Kawasaki M, Tamada A, Nagata S, Kagamiyama H, Mori K. Overlapping and differential expression of BIG-2, BIG-1, TAG-1, and F3: four members of an axon associated cell adhesion molecule subgroup of the immunoglobulin superfamily. J Neurobiol 1995; 28:51-69; PMID:8586965; https://doi.org/10.1002/neu.480280106
   PubMedGoogle Scholar
• Montag-Sallaz M, Schachner M, Montag D. Misguided axonal projections, neural cell adhesion molecule 180 mRNA upregulation, and altered behavior in mice deficient for the close homolog of L1. Mol Cell Biol 2002; 22:7967-81; PMID:12391163; https://doi.org/10.1128/MCB.22.22.7967-7981.2002
   PubMed Web of Science ®Google Scholar
• Mercati O, Danckaert A, Andre-Leroux G, Bellinzoni M, Gouder L, Watanabe K, et al. Contactin 4, -5 and -6 differentially regulate neuritogenesis while they display identical PTPRG binding sites. Biol Open 2013; 2:324-34; PMID:23519440; https://doi.org/10.1242/bio.20133343
   PubMed Web of Science ®Google Scholar
• Frints SG, Marynen P, Hartmann D, Fryns JP, Steyaert J, Schachner M, Rolf B, Craessaerts K, Snellinx A, Hollanders K, D'Hooge R, De Deyn PP, Froyen G. CALL interrupted in a patient with non-specific mental retardation: gene dosage-dependent alteration of murine brain development and behavior. Hum Mol Genet 2003; 12:1463-74. PMID:12812975; PMID:12812975; https://doi.org/10.1093/hmg/ddg165
   PubMed Web of Science ®Google Scholar
• He LH, Ma Q, Shi YH, Ge J, Zhao HM, Li SF, Tong ZS. CHL1 is involved in human breast tumorigenesis and progression. Biochem Biophys Res Commun 2013; 438:433-8; PMID:23906755; https://doi.org/10.1016/j.bbrc.2013.07.093
   PubMed Web of Science ®Google Scholar